Betaine anhydrous

ๆ— ๆฐด็”œ่œ็ขฑ

Report date: 2026/04/01 17:52:54
NME

Base Information

Drug NameBetaine anhydrous
Drug Alias Name็”œ่œ็ขฑ็›้…ธ็›TrimethylglycineGlycocoll betaine็”œ่œ็กท็›้…ธ็›็›้…ธ็”œ่œ็กท +[9]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsObesityGlucose Metabolism DisordersHyperhomocysteinemia +[7]ย 
Global Approved IndicationsHomocystinuria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/25
Country/TerritoryUnited StatesEUMainland China +[4]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesOrphan Europe Sarl
China Registration ClassN/A

Develop Information

Active CompaniesYichunwujiashenyaoyeyouxianzerengongsiReqmedEton Pharmaceuticals Inc +[6]ย 
Inactive CompaniesJoslin Diabetes Center IncUniversity Of North Carolina At Chapel HillOrphan Europe
Active IndicationsHyperhomocysteinemiaHomocystinuriaMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsObesityGlucose Metabolism DisordersHyperoxaluria +[4]ย 

Other Information

ATC CodeA16AA06
Related LinksWikipediaKEGG